ClearWay Rx Readmission Registry

Trial Profile

ClearWay Rx Readmission Registry

Phase of Trial: Phase III

Latest Information Update: 11 Feb 2016

At a glance

  • Drugs Abciximab (Primary) ; Eptifibatide (Primary)
  • Indications Acute coronary syndromes
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Jan 2016 Status changed from recruiting to completed as per the record.
    • 23 May 2013 Planned End Date changed from 1 Dec 2012 to 1 Jun 2014 as reported by
    • 31 Aug 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top